F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 55 filers reported holding F-STAR THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 14.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $4,751,938 | +23.4% | 751,889 | 0.0% | 0.11% | +15.2% |
Q3 2022 | $3,850,000 | -18.2% | 751,889 | 0.0% | 0.10% | -27.7% |
Q2 2022 | $4,707,000 | +76.4% | 751,889 | 0.0% | 0.14% | +104.5% |
Q1 2022 | $2,669,000 | -29.3% | 751,889 | 0.0% | 0.07% | -23.0% |
Q4 2021 | $3,774,000 | -51.1% | 751,889 | -28.7% | 0.09% | -46.3% |
Q3 2021 | $7,717,000 | -14.8% | 1,054,232 | 0.0% | 0.16% | -9.5% |
Q2 2021 | $9,056,000 | – | 1,054,232 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |